Sernova (TSE:SVA) Reaches New 52-Week Low – Should You Sell?

Sernova Corp. (TSE:SVA) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.13 and last traded at C$0.14, with a volume of 20880 shares. The stock had previously closed at C$0.13.

Sernova Trading Up 3.8%

The firm has a market cap of C$44.37 million, a PE ratio of -2.70 and a beta of 0.73. The company has a debt-to-equity ratio of -4.40, a current ratio of 0.32 and a quick ratio of 18.11. The company’s 50 day moving average price is C$0.15 and its 200 day moving average price is C$0.17.

Sernova Company Profile

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.